Trial Profile
A Phase I, Open-label, Randomised, Crossover Study in 3 Parallel Groups to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2022
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary) ; Ketoconazole; Omeprazole; Rifampicin
- Indications Cancer pain; Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Neuropathic pain; Peptic ulcer; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Jazz Pharmaceuticals Inc
- 23 Mar 2011 New trial record